Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

OBERD powers Regenerative Orthobiologics Registry to advance orthopaedics

OBERD
Posted on: 25 Jul 17

COLUMBIA, Mo., July 24, 2017 /PRNewswire/ -- Columbia, Missouri-based Universal Research Solutions (a.k.a. OBERD) has joined the Regenerative SportsCare Institute, Orthohealing Center and the University of California: Davis to create the Regenerative Orthobiologics Registry (ROR) powered by OBERD.  ROR is the official registry of The Orthobiologic Institute (TOBI), and leverages OBERD's healthcare data registry platform to advance evidence-based care to standardize regenerative orthobiologics procedures.

ROR's commitment to empowering healthcare organizations to enhance the patient experience and benchmark performance aligns with OBERD's expertise in musculoskeletal outcomes data collection. OBERD's registries provide large data sets for benchmarking, research, and quality improvement initiatives. Its family of musculoskeletal registries has been established based on procedure, under specific platforms including: hip and knee; hand and wrist; foot and ankle; spine; and sports medicine.

"The Regenerative Orthobiologics Registry was created as a united initiative to improve data collection in the field of Orthobiologics," said Kwadwo Boachie-Adjei, ROR's Chief Technology Officer. "ROR offers valuable opportunities to learn, connect and contribute, and is designed to help practitioners and researchers navigate the changing landscape of orthobiologics in regenerative medicine by providing access to high quality data sets for benchmarking, research, and quality improvement."

ROR seeks to become the international registry for regenerative orthobiologics, beginning with capturing 90% of all regenerative medicine procedures in the U.S. within the next 5 years, and to leverage this comprehensive data to:

Enhance orthobiologic quality of care

Improve patient outcomes and safety

Manage and reduce costs

Advance orthobiologic science and bioengineering

"OBERD is delighted to support this initiative and provide the tools to collect essential data in this exciting medical field," said Andrew Clement, Chief Commercial Officer. "The Registry will enable users to easily contribute to a national database that, through the use of OBERD's infinite range of filter combinations, can provide the raw data for innovative research in the future."

About Regenerative Orthobiologics Registry
The Regenerative Orthobiologics Registry (ROR) is a stand-alone non-profit (501c3) founded in 2017 by Dr. Gregory Lutz, Dr. Steven Sampson, Dr. Hunter Vincent, and Dr. Christopher Lutz. A multi-stakeholder, independent organization with diverse national and international constituents led by top Physiatrists and Interventionalists, ROR aims to connect the orthobiologics community with this international data registry.
Learn more at www.roregistry.org

About Universal Research Solutions (OBERD)
Universal Research Solutions (a.k.a. OBERD) owns, develops, implements and supports the OBERD (Outcomes Based Electronic Research Database) system. OBERD optimizes the data collection necessary to empower evidence-based medical practice, improve the quality and efficacy of care and advance clinical decision-making and patient understanding. OBERD has been collecting patient outcomes data in orthopaedics for over 7 years, with over 10 million scored forms from over 2 million patients in its database. It includes a QCDR, with CMS-approved measures specific to orthopaedics. For more information, visit www.oberd.com or follow the company on Twitter @oberdnews.

For more information:
www.oberd.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 25/07/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.